BioSpace News Archive

Press Releases

Immunome Announces IND Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors

September 30, 2026
·
5 min read
Press Releases

Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards

September 30, 2026
·
4 min read
Press Releases

Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at ASTRO 2026

September 30, 2026
·
9 min read
Press Releases

Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

September 30, 2026
·
7 min read
Press Releases

Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatment of Eosinophilic Esophagitis

September 30, 2026
·
12 min read
Press Releases

Immutep Receives ~A$0.86 Million R&D Tax Incentive

September 30, 2026
·
3 min read
Press Releases

Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences

September 30, 2026
·
7 min read
Press Releases

DiFusion Activates Operating Board to Scale Therapeutic Biomaterials Platform

September 30, 2026
·
7 min read
Press Releases

BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules

September 30, 2026
·
5 min read
Press Releases

Avacta Group plc: Interim Results for the Six Months to June 30, 2026, and Business Update

September 30, 2026
·
44 min read